Glucosylceramidase (3.2.1.45)

Industry

CPC
C12Y302/01045

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y302/00Hydrolases acting on glycosyl compounds

Current Industry

C12Y302/01045Glucosylceramidase (3.2.1.45)

Industries

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for treatment of GCase related disease states
- Patent number 12,133,880
- Issue date Nov 5, 2024
- Children's Hospital Medical Center
- Ying Sun
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for CNS delivery of iduronate-2-sulfatase
- Patent number 12,121,569
- Issue date Oct 22, 2024
- Takeda Pharmaceutical Company Limited
- Gaozhong Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Integrated continuous manufacturing of therapeutic protein drug sub...
- Patent number 12,110,312
- Issue date Oct 8, 2024
- Genzyme Corporation
- Konstantin Konstantinov
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Methods for treating neurological symptoms associated with lysosoma...
- Patent number 12,083,115
- Issue date Sep 10, 2024
- Genzyme Corporation
- Nigel Patrick Somerville Crawford
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy for neurodegenerative disorders
- Patent number 12,049,626
- Issue date Jul 30, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for the treatment of cytoplasmic glycogen...
- Patent number 12,036,190
- Issue date Jul 16, 2024
- Duke University
- Priya Kishnani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,993,790
- Issue date May 28, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ICAM-1 targeted fusion enzymes
- Patent number 11,912,745
- Issue date Feb 27, 2024
- University of Maryland, College Park
- Silvia Muro
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,903,985
- Issue date Feb 20, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fusion proteins comprising enzyme replacement therapy enzymes
- Patent number 11,866,742
- Issue date Jan 9, 2024
- Denali Therapeutics Inc.
- Anastasia Henry
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,807,849
- Issue date Nov 7, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,802,294
- Issue date Oct 31, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified recombinant lysosomal alpha-galactosidase A and aspartylgl...
- Patent number 11,708,569
- Issue date Jul 25, 2023
- University of Copenhagen
- Claus Kristensen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for the treatment of steatosis-associated...
- Patent number 11,690,812
- Issue date Jul 4, 2023
- Duke University
- Dwight D. Koeberl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,661,585
- Issue date May 30, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,655,460
- Issue date May 23, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,613,737
- Issue date Mar 28, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
In vitro and in vivo enrichment strategy targeting lymphocytes deri...
- Patent number 11,597,917
- Issue date Mar 7, 2023
- The Medical College of Wisconsin, Inc.
- Jeffrey A. Medin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treating Gaucher disease
- Patent number 11,571,466
- Issue date Feb 7, 2023
- Takeda Pharmaceutical Company Limited
- Peter Francis Daniel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CNS delivery of therapeutic agents
- Patent number 11,471,516
- Issue date Oct 18, 2022
- Shire Human Genetic Therapies, Inc.
- Pericles Calias
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycosylated lysosomal proteins, method of production and uses
- Patent number 11,401,563
- Issue date Aug 2, 2022
- eleva GmbH
- Paulina Dabrowska-Schlepp
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Progranulin (PGRN) fragments and derivatives for treatment or allev...
- Patent number 11,390,656
- Issue date Jul 19, 2022
- New York University
- Chuanju Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapy for lysosomal storage diseases
- Patent number 11,369,693
- Issue date Jun 28, 2022
- Genzyme Corporation
- James Dodge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for CNS delivery of iduronate-2-sulfatase
- Patent number 11,260,112
- Issue date Mar 1, 2022
- Shire Human Genetic Therapies, Inc.
- Gaozhong Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treatment of GCASE related disease states
- Patent number 11,260,106
- Issue date Mar 1, 2022
- Children's Hospital Medical Center
- Ying Sun
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ICAM-1 targeted fusion enzymes
- Patent number 11,248,029
- Issue date Feb 15, 2022
- University of Maryland, College Park
- Silvia Muro
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for enhancing folding and transport of misfolded glucocerebr...
- Patent number 11,160,773
- Issue date Nov 2, 2021
- The Hospital for sick Children
- Don J. Mahuran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic fusion protein comprising an alpha-n-acetylglucosaminid...
- Patent number 11,065,307
- Issue date Jul 20, 2021
- Shire Human Genetic Therapies, Inc.
- Michael F. Concino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for CNS delivery of heparan n-sulfatase
- Patent number 11,065,308
- Issue date Jul 20, 2021
- Shire Human Genetic Therapies, Inc.
- Farah Natoli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,060,113
- Issue date Jul 13, 2021
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ICAM-1 TARGETED FUSION ENZYMES
- Publication number 20240327475
- Publication date Oct 3, 2024
- University of Maryland, College Park
- Silvia Muro
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYPEPTIDE
- Publication number 20240261433
- Publication date Aug 8, 2024
- FREELINE THERAPEUTICS LIMITED
- Fabrizio COMPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTE...
- Publication number 20240167010
- Publication date May 23, 2024
- WUXI BIOLOGICS IRELAND LIMITED
- Liqin XU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYSTEMS AND METHODS FOR PROTEIN EXPRESSION
- Publication number 20240141373
- Publication date May 2, 2024
- Excepgen Inc.
- Barbara MERTINS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20240123003
- Publication date Apr 18, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ASSAY FOR MEASURING POTENCY OF GENE THERAPY DRUG PRODUCT
- Publication number 20240044869
- Publication date Feb 8, 2024
- Prevail Therapeutics, Inc.
- Mary NG
- G01 - MEASURING TESTING
Information Patent Application
DOPAMINERGIC NEURONS COMPRISING MUTATIONS AND METHODS OF USE THEREOF
- Publication number 20240034992
- Publication date Feb 1, 2024
- FUJIFILM Cellular Dynamics, Inc.
- Deepika RAJESH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LYSOSOMAL ENZYMES MODIFIED BY CELL BASED GLYCOENGINEERING
- Publication number 20230416715
- Publication date Dec 28, 2023
- UNIVERSITY OF COPENHAGEN
- Claus KRISTENSEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Novel In Vitro and In Vivo Enrichment Strategy Targeting Lymphocyte...
- Publication number 20230332112
- Publication date Oct 19, 2023
- The Medical College of Wisconsin, Inc.
- Jeffrey A. Medin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20230310654
- Publication date Oct 5, 2023
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods and Compositions for the Treatment of Steatosis-Associated...
- Publication number 20230285328
- Publication date Sep 14, 2023
- DUKE UNIVERSITY
- Dwight D. Koeberl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods and Compositions for the Treatment of Steatosis-Associated...
- Publication number 20230285329
- Publication date Sep 14, 2023
- DUKE UNIVERSITY
- Dwight D. Koeberl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTE...
- Publication number 20230287378
- Publication date Sep 14, 2023
- WUXI BIOLOGICS IRELAND LIMITED
- Liqin XU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VIRAL PARTICLES FOR USE IN TREATING TAUOPATHIES SUCH AS ALZHEIMER'S...
- Publication number 20230277687
- Publication date Sep 7, 2023
- FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA
- Gloria GONZÁLEZ-ASEGUINOLAZA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDER...
- Publication number 20230227802
- Publication date Jul 20, 2023
- VOYAGER THERAPEUTICS, INC.
- Giridhar MURLIDHARAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM, ARDS, AND ACU...
- Publication number 20230226159
- Publication date Jul 20, 2023
- The Cleveland Clinic Foundation
- Xiaoxia Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERMOSTABLE GLUCOCEREBROSIDASE
- Publication number 20230183665
- Publication date Jun 15, 2023
- TEIKYO UNIVERSITY
- Jinichiro KOGA
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
CNS DELIVERY OF THERAPEUTIC AGENTS
- Publication number 20230165942
- Publication date Jun 1, 2023
- Shire Human Genetic Therapies, Inc
- Pericles Calias
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING GAUCHER THERA...
- Publication number 20230134550
- Publication date May 4, 2023
- GENERATION BIO CO.
- Douglas Anthony Kerr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VARIANTS OF BETA-GLUCOCEREBROSIDASE FOR USE IN TREATING GAUCHER DIS...
- Publication number 20230132790
- Publication date May 4, 2023
- Yeda Research and Development Co. Ltd.
- Anthony H. FUTERMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING FARBER DISEASE
- Publication number 20230123505
- Publication date Apr 20, 2023
- ACERAGEN, INC.
- Eric GAUKEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHO...
- Publication number 20230085357
- Publication date Mar 16, 2023
- Xeris Pharmaceuticals, inc.
- Martin DONOVAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRANSPOSON-BASED MODULATION OF GBA1 AND RELATED COMPOSITIONS AND US...
- Publication number 20230081881
- Publication date Mar 16, 2023
- Aspen Neuroscience, Inc.
- Andres BRATT-LEAL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE
- Publication number 20230026836
- Publication date Jan 26, 2023
- Shire Human Genetic Therapies, Inc
- Gaozhong Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATMENT OF GCASE RELATED DISEASE STATES
- Publication number 20230000948
- Publication date Jan 5, 2023
- Children's Hospital Medical Center
- Ying Sun
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
POLYPEPTIDE-FC CONJUGATE WITH ATTENUATED IMMUNE RESPONSE
- Publication number 20220354958
- Publication date Nov 10, 2022
- Hanmi Pharm. Co., Ltd.
- Jin Young KIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLUCOCEREBROSIDASE MUTANTS
- Publication number 20220325265
- Publication date Oct 13, 2022
- HOFFMANN-LA ROCHE INC.
- Joerg BENZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VIRAL PARTICLES FOR USE IN TREATING SYNUCLEINOPATHIES SUCH AS PARKI...
- Publication number 20220298528
- Publication date Sep 22, 2022
- UCB Biopharma SRL
- Gloria GONZALEZ ASEGUINOLAZA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20220211871
- Publication date Jul 7, 2022
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
ICAM-1 TARGETED FUSION ENZYMES
- Publication number 20220204573
- Publication date Jun 30, 2022
- University of Maryland, College Park
- Silvia Muro
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Glucosylceramidase (3.2.1.45)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Compositions and methods for treatment of GCase related disease states

Methods and compositions for CNS delivery of iduronate-2-sulfatase

Integrated continuous manufacturing of therapeutic protein drug sub...

Methods for treating neurological symptoms associated with lysosoma...

Gene therapy for neurodegenerative disorders

Methods and compositions for the treatment of cytoplasmic glycogen...

Gene therapies for lysosomal disorders

ICAM-1 targeted fusion enzymes

Gene therapies for lysosomal disorders

Fusion proteins comprising enzyme replacement therapy enzymes

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Modified recombinant lysosomal alpha-galactosidase A and aspartylgl...

Methods and compositions for the treatment of steatosis-associated...

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

In vitro and in vivo enrichment strategy targeting lymphocytes deri...

Compositions and methods for treating Gaucher disease

CNS delivery of therapeutic agents

Glycosylated lysosomal proteins, method of production and uses

Progranulin (PGRN) fragments and derivatives for treatment or allev...

Gene therapy for lysosomal storage diseases

Methods and compositions for CNS delivery of iduronate-2-sulfatase

Compositions and methods for treatment of GCASE related disease states

ICAM-1 targeted fusion enzymes

Method for enhancing folding and transport of misfolded glucocerebr...

Therapeutic fusion protein comprising an alpha-n-acetylglucosaminid...

Methods and compositions for CNS delivery of heparan n-sulfatase

Gene therapies for lysosomal disorders

Patents Applicationslast 30 patents

ICAM-1 TARGETED FUSION ENZYMES

POLYPEPTIDE

A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTE...

SYSTEMS AND METHODS FOR PROTEIN EXPRESSION

GENE THERAPIES FOR LYSOSOMAL DISORDERS

ASSAY FOR MEASURING POTENCY OF GENE THERAPY DRUG PRODUCT

DOPAMINERGIC NEURONS COMPRISING MUTATIONS AND METHODS OF USE THEREOF

LYSOSOMAL ENZYMES MODIFIED BY CELL BASED GLYCOENGINEERING

Novel In Vitro and In Vivo Enrichment Strategy Targeting Lymphocyte...

GENE THERAPIES FOR LYSOSOMAL DISORDERS

Methods and Compositions for the Treatment of Steatosis-Associated...

Methods and Compositions for the Treatment of Steatosis-Associated...

A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTE...

VIRAL PARTICLES FOR USE IN TREATING TAUOPATHIES SUCH AS ALZHEIMER'S...

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDER...

METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM, ARDS, AND ACU...

THERMOSTABLE GLUCOCEREBROSIDASE

CNS DELIVERY OF THERAPEUTIC AGENTS

NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING GAUCHER THERA...

VARIANTS OF BETA-GLUCOCEREBROSIDASE FOR USE IN TREATING GAUCHER DIS...

METHODS FOR TREATING FARBER DISEASE

INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHO...

TRANSPOSON-BASED MODULATION OF GBA1 AND RELATED COMPOSITIONS AND US...

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE

COMPOSITIONS AND METHODS FOR TREATMENT OF GCASE RELATED DISEASE STATES

POLYPEPTIDE-FC CONJUGATE WITH ATTENUATED IMMUNE RESPONSE

GLUCOCEREBROSIDASE MUTANTS

VIRAL PARTICLES FOR USE IN TREATING SYNUCLEINOPATHIES SUCH AS PARKI...

GENE THERAPIES FOR LYSOSOMAL DISORDERS

ICAM-1 TARGETED FUSION ENZYMES